CLINICAL_TRIALS
trial_result
· 2016-02-03
Clinical Trial Update: Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone [Phase 3]
Summary
Phase 3 trial assessment of lubiprostone for opioid-induced bowel dysfunction has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sucampo Pharma Americas, LLC | Conditions: Opioid-Induced Bowel Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2016-02-03